Asim Mian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Asim Mian has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
- Mohamad Abdalkader
Boston Medical Center
4 shared publications - Bindu N. Setty
School of Medicine, Department of Radiology, Boston University, Boston, United States
3 shared publications Osamu Sakai
Department of Radiology, Boston Medical Center, Boston University School of Medicine, FGH Building, 3, Boston, MA 02118, USA
3 shared publications- Osamu Sakai
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
3 shared publications - Anurag Sahoo
Department of Neurosurgery, Rutgers the State University of New Jersey, Newark
2 shared publications - Armand Keating
Cell Therapy Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
2 shared publications
Latest Publications
- 11 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (2) , 482-488
Outcome Prediction in Pediatric Traumatic Brain Injury Utilizing Social Determinants of Health and Machine Learning Methods
Considerable socioeconomic disparities exist among pediatric traumatic brain injury (TBI) patients. This study aims to analyze the effects of social determinants of health on head injury outcomes and to create a novel machine-learning algorithm (MLA) that incorporates socioeconomic factors to predict the likelihood of a positive or negative trauma-related finding on head computed tomography (CT). A cohort of blunt trauma patients under age 15 who presented to the largest safety net hospital in New England between January 2006 and December 2013 (n=211) was included in this study. Patient socioeconomic data such as race, language, household income, and insurance type were collected alongside other parameters like Injury Severity Score (ISS), age, sex, and mechanism of injury. Multivariable analysis was performed to identify significant factors in predicting a positive head CT outcome. The cohort was split into 80% training (168 samples) and 20% testing (43 samples) datasets using stratified sampling. Twenty-two multi-parametric MLAs were trained with 5-fold cross-validation and hyperparameter tuning via GridSearchCV, and top-performing models were evaluated on the test dataset. Significant factors associated with pediatric head CT outcome included ISS, age, and insurance type (p<0.05). The age of the subjects with a clinically relevant trauma-related head CT finding (median= 1.8 years) was significantly different from the age of patients without such findings (median= 9.1 years). These predictors were utilized to train the machine learning models. With ISS, the Fine Gaussian SVM achieved the highest test AUC (0.923), with accuracy=0.837, sensitivity=0.647, and specificity=0.962. The Coarse Tree yielded accuracy=0.837, AUC=0.837, sensitivity=0.824, and specificity=0.846. Without ISS, the Narrow Neural Network performed best with accuracy=0.837, AUC=0.857, sensitivity=0.765, and specificity=0.885. Key predictors of clinically relevant head CT findings in pediatric TBI include ISS, age, and social determinants of health, with children under 5 at higher risk. A novel Fine Gaussian SVM model outperformed other MLA, offering high accuracy in predicting outcomes. This tool shows promise for improving clinical decisions while minimizing radiation exposure in children. TBI = Traumatic Brain Injury; ISS = Injury Severity Score; MLA = Machine Learning Algorithm; CT = Computed Tomography; AUC = Area Under the Curve.
- 11 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (2) , 482-488
Outcome Prediction in Pediatric Traumatic Brain Injury Utilizing Social Determinants of Health and Machine Learning Methods
Considerable socioeconomic disparities exist among pediatric traumatic brain injury (TBI) patients. This study aims to analyze the effects of social determinants of health on head injury outcomes and to create a novel machine-learning algorithm (MLA) that incorporates socioeconomic factors to predict the likelihood of a positive or negative trauma-related finding on head computed tomography (CT). A cohort of blunt trauma patients under age 15 who presented to the largest safety net hospital in New England between January 2006 and December 2013 (n=211) was included in this study. Patient socioeconomic data such as race, language, household income, and insurance type were collected alongside other parameters like Injury Severity Score (ISS), age, sex, and mechanism of injury. Multivariable analysis was performed to identify significant factors in predicting a positive head CT outcome. The cohort was split into 80% training (168 samples) and 20% testing (43 samples) datasets using stratified sampling. Twenty-two multi-parametric MLAs were trained with 5-fold cross-validation and hyperparameter tuning via GridSearchCV, and top-performing models were evaluated on the test dataset. Significant factors associated with pediatric head CT outcome included ISS, age, and insurance type (p<0.05). The age of the subjects with a clinically relevant trauma-related head CT finding (median= 1.8 years) was significantly different from the age of patients without such findings (median= 9.1 years). These predictors were utilized to train the machine learning models. With ISS, the Fine Gaussian SVM achieved the highest test AUC (0.923), with accuracy=0.837, sensitivity=0.647, and specificity=0.962. The Coarse Tree yielded accuracy=0.837, AUC=0.837, sensitivity=0.824, and specificity=0.846. Without ISS, the Narrow Neural Network performed best with accuracy=0.837, AUC=0.857, sensitivity=0.765, and specificity=0.885. Key predictors of clinically relevant head CT findings in pediatric TBI include ISS, age, and social determinants of health, with children under 5 at higher risk. A novel Fine Gaussian SVM model outperformed other MLA, offering high accuracy in predicting outcomes. This tool shows promise for improving clinical decisions while minimizing radiation exposure in children. TBI = Traumatic Brain Injury; ISS = Injury Severity Score; MLA = Machine Learning Algorithm; CT = Computed Tomography; AUC = Area Under the Curve.
- Open Access
- 23 January 2025
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 5
Consensus recommendations for clinical functional MRI applied to language mapping
Ample reports highlight fMRI’s added value to guide neurosurgical interventions near brain regions supporting speech and language. However, fMRI’s usefulness for clinical language mapping remains controversial, partly fueled by 1) differences from clinical standard tools it is often compared against, and 2) wide heterogeneity in how data are acquired, analyzed and interpreted. Both factors limit objective assessment of the benefits and efficacy of presurgical fMRI. This underscores the need for standardization of fMRI protocols to enable data pooling across centers and facilitate learning from patient outcomes. The OHBM Working Group on clinical fMRI language mapping was formed in 2017. Its scope was to review and propose best practice recommendations addressing specific challenges posed by applications in patient populations. Objectives were to: 1) consider language tasks and designs, optimized for specific clinical objectives, and incorporating modifications for patients with existing impairments; 2) offer practical guidance, based on high-quality research, for each step from fMRI acquisition and analysis to reporting individual patients’ data. In considering these challenges we focus on implementations that have proven feasible based on approaches in active use today. When widely available practices deviate from optimal practices, we highlight emerging developments meriting further evaluation and incorporation into clinical use. This document was created in collaboration with the OHBM Committee on Best Practices, incorporating community feedback. It aims to provide a framework for improved standardization of fMRI to enable much-needed evaluations of its ultimate goals; namely, minimization of invasive intraoperative testing and, ultimately, of new post-operative language deficits. Accordingly, the single strongest recommendation is for greater transparency and reporting of longitudinal outcomes in patients undergoing clinical fMRI.
- 23 January 2025
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 5
Open AccessConsensus recommendations for clinical functional MRI applied to language mapping
Ample reports highlight fMRI’s added value to guide neurosurgical interventions near brain regions supporting speech and language. However, fMRI’s usefulness for clinical language mapping remains controversial, partly fueled by 1) differences from clinical standard tools it is often compared against, and 2) wide heterogeneity in how data are acquired, analyzed and interpreted. Both factors limit objective assessment of the benefits and efficacy of presurgical fMRI. This underscores the need for standardization of fMRI protocols to enable data pooling across centers and facilitate learning from patient outcomes. The OHBM Working Group on clinical fMRI language mapping was formed in 2017. Its scope was to review and propose best practice recommendations addressing specific challenges posed by applications in patient populations. Objectives were to: 1) consider language tasks and designs, optimized for specific clinical objectives, and incorporating modifications for patients with existing impairments; 2) offer practical guidance, based on high-quality research, for each step from fMRI acquisition and analysis to reporting individual patients’ data. In considering these challenges we focus on implementations that have proven feasible based on approaches in active use today. When widely available practices deviate from optimal practices, we highlight emerging developments meriting further evaluation and incorporation into clinical use. This document was created in collaboration with the OHBM Committee on Best Practices, incorporating community feedback. It aims to provide a framework for improved standardization of fMRI to enable much-needed evaluations of its ultimate goals; namely, minimization of invasive intraoperative testing and, ultimately, of new post-operative language deficits. Accordingly, the single strongest recommendation is for greater transparency and reporting of longitudinal outcomes in patients undergoing clinical fMRI.
- 2 May 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (6) , 701-707
Contrast Staining in Noninfarcted Tissue after Endovascular Treatment of Acute Ischemic Stroke
BACKGROUND AND PURPOSE: Contrast staining is a common finding after endovascular treatment of acute ischemic stroke. It typically occurs in infarcted tissue and is considered an indicator of irreversible brain damage. Contrast staining in noninfarcted tissue has not been systematically investigated. We sought to assess the incidence, risk factors, and clinical significance of contrast staining in noninfarcted tissue after endovascular treatment. MATERIALS AND METHODS: We conducted a retrospective review of consecutive patients who underwent endovascular treatment for anterior circulation large-vessel occlusion acute ischemic stroke. Contrast staining, defined as new hyperdensity on CT after endovascular treatment, was categorized as either contrast staining in infarcted tissue if the stained region demonstrated restricted diffusion on follow-up MR imaging or contrast staining in noninfarcted tissue if the stained region demonstrated no restricted diffusion. Baseline differences between patients with and without contrast staining in noninfarcted tissue were compared. Logistic regression was used to identify independent associations for contrast staining in noninfarcted tissue after endovascular treatment. RESULTS: Among 194 patients who underwent endovascular treatment for large-vessel occlusion acute ischemic stroke and met the inclusion criteria, contrast staining in infarcted tissue was noted in 52/194 (26.8%) patients; contrast staining in noninfarcted tissue, in 26 (13.4%) patients. Both contrast staining in infarcted tissue and contrast staining in noninfarcted tissue were noted in 5.6% (11/194). Patients with contrast staining in noninfarcted tissue were found to have a higher likelihood of having an ASPECTS of 8–10, to be associated with contrast staining in infarcted tissue, and to achieve successful reperfusion compared with those without contrast staining in noninfarcted tissue. In contrast staining in noninfarcted tissue regions, the average attenuation was 40 HU, significantly lower than the contrast staining in infarcted tissue regions (53 HU). None of the patients with contrast staining in noninfarcted tissue had clinical worsening during their hospital stay. The median discharge mRS was significantly lower in patients with contrast staining in noninfarcted tissue than in those without (3 versus 4; P = .018). No independent predictors of contrast staining in noninfarcted tissue were found. CONCLUSIONS: Contrast staining can be seen outside the infarcted tissue after endovascular treatment of acute ischemic stroke, likely attributable to the reversible disruption of the BBB in ischemic but not infarcted tissue. While generally benign, understanding its characteristics is important because it may mimic pathologic conditions such as infarcted tissue and cerebral edema.
- 2 May 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (6) , 701-707
Contrast Staining in Noninfarcted Tissue after Endovascular Treatment of Acute Ischemic Stroke
BACKGROUND AND PURPOSE: Contrast staining is a common finding after endovascular treatment of acute ischemic stroke. It typically occurs in infarcted tissue and is considered an indicator of irreversible brain damage. Contrast staining in noninfarcted tissue has not been systematically investigated. We sought to assess the incidence, risk factors, and clinical significance of contrast staining in noninfarcted tissue after endovascular treatment. MATERIALS AND METHODS: We conducted a retrospective review of consecutive patients who underwent endovascular treatment for anterior circulation large-vessel occlusion acute ischemic stroke. Contrast staining, defined as new hyperdensity on CT after endovascular treatment, was categorized as either contrast staining in infarcted tissue if the stained region demonstrated restricted diffusion on follow-up MR imaging or contrast staining in noninfarcted tissue if the stained region demonstrated no restricted diffusion. Baseline differences between patients with and without contrast staining in noninfarcted tissue were compared. Logistic regression was used to identify independent associations for contrast staining in noninfarcted tissue after endovascular treatment. RESULTS: Among 194 patients who underwent endovascular treatment for large-vessel occlusion acute ischemic stroke and met the inclusion criteria, contrast staining in infarcted tissue was noted in 52/194 (26.8%) patients; contrast staining in noninfarcted tissue, in 26 (13.4%) patients. Both contrast staining in infarcted tissue and contrast staining in noninfarcted tissue were noted in 5.6% (11/194). Patients with contrast staining in noninfarcted tissue were found to have a higher likelihood of having an ASPECTS of 8–10, to be associated with contrast staining in infarcted tissue, and to achieve successful reperfusion compared with those without contrast staining in noninfarcted tissue. In contrast staining in noninfarcted tissue regions, the average attenuation was 40 HU, significantly lower than the contrast staining in infarcted tissue regions (53 HU). None of the patients with contrast staining in noninfarcted tissue had clinical worsening during their hospital stay. The median discharge mRS was significantly lower in patients with contrast staining in noninfarcted tissue than in those without (3 versus 4; P = .018). No independent predictors of contrast staining in noninfarcted tissue were found. CONCLUSIONS: Contrast staining can be seen outside the infarcted tissue after endovascular treatment of acute ischemic stroke, likely attributable to the reversible disruption of the BBB in ischemic but not infarcted tissue. While generally benign, understanding its characteristics is important because it may mimic pathologic conditions such as infarcted tissue and cerebral edema.
- Open Access
- 11 February 2024
- Published by MDPI AG in Tomography
- Vol. 10 (2) , 266-276
Differential Assessment of Internal Jugular Vein Stenosis in Patients Undergoing CT and MRI with Contrast
Objective: Internal Jugular Vein Stenosis (IJVS) is hypothesized to play a role in the pathogenesis of diverse neurological diseases. We sought to evaluate differences in IJVS assessment between CT and MRI in a retrospective patient cohort. Methods: We included consecutive patients who had both MRI of the brain and CT of the head and neck with contrast from 1 June 2021 to 30 June 2022 within the same admission. The degree of IJVS was categorized into five grades (0–IV). Results: A total of 35 patients with a total of 70 internal jugular (IJ) veins were included in our analysis. There was fair intermodality agreement in stenosis grades (κ = 0.220, 95% C.I. = [0.029, 0.410]), though categorical stenosis grades were significantly discordant between imaging modalities, with higher grades more frequent in MRI (χ2 = 27.378, p = 0.002). On CT-based imaging, Grade III or IV stenoses were noted in 17/70 (24.2%) IJs, whereas on MRI-based imaging, Grade III or IV stenoses were found in 40/70 (57.1%) IJs. Among veins with Grade I-IV IJVS, MRI stenosis estimates were significantly higher than CT stenosis estimates (77.0%, 95% C.I. [35.9–55.2%] vs. 45.6%, 95% C.I. [35.9–55.2%], p < 0.001). Conclusion: MRI with contrast overestimates the degree of IJVS compared to CT with contrast. Consideration of this discrepancy should be considered in diagnosis and treatment planning in patients with potential IJVS-related symptoms.
- 11 February 2024
- Published by MDPI AG in Tomography
- Vol. 10 (2) , 266-276
Open AccessDifferential Assessment of Internal Jugular Vein Stenosis in Patients Undergoing CT and MRI with Contrast
Objective: Internal Jugular Vein Stenosis (IJVS) is hypothesized to play a role in the pathogenesis of diverse neurological diseases. We sought to evaluate differences in IJVS assessment between CT and MRI in a retrospective patient cohort. Methods: We included consecutive patients who had both MRI of the brain and CT of the head and neck with contrast from 1 June 2021 to 30 June 2022 within the same admission. The degree of IJVS was categorized into five grades (0–IV). Results: A total of 35 patients with a total of 70 internal jugular (IJ) veins were included in our analysis. There was fair intermodality agreement in stenosis grades (κ = 0.220, 95% C.I. = [0.029, 0.410]), though categorical stenosis grades were significantly discordant between imaging modalities, with higher grades more frequent in MRI (χ2 = 27.378, p = 0.002). On CT-based imaging, Grade III or IV stenoses were noted in 17/70 (24.2%) IJs, whereas on MRI-based imaging, Grade III or IV stenoses were found in 40/70 (57.1%) IJs. Among veins with Grade I-IV IJVS, MRI stenosis estimates were significantly higher than CT stenosis estimates (77.0%, 95% C.I. [35.9–55.2%] vs. 45.6%, 95% C.I. [35.9–55.2%], p < 0.001). Conclusion: MRI with contrast overestimates the degree of IJVS compared to CT with contrast. Consideration of this discrepancy should be considered in diagnosis and treatment planning in patients with potential IJVS-related symptoms.
- 23 August 2023
- Published by Elsevier in World Neurosurgery
- Vol. 179, e281-e287
Crossover from Femoral to Radial Access During Mechanical Thrombectomy of Large Vessel Occlusion Stroke
- 23 August 2023
- Published by Elsevier in World Neurosurgery
- Vol. 179, e281-e287
Crossover from Femoral to Radial Access During Mechanical Thrombectomy of Large Vessel Occlusion Stroke
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
Supplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
Supplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
Supplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
Supplementary Data from Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
- 1 May 2022
- Published by Elsevier in Academic Radiology
- Vol. 29, S18-S26
ACGME Diagnostic Radiology Milestones 2.0: the Time is Now
- 1 May 2022
- Published by Elsevier in Academic Radiology
- Vol. 29, S18-S26
ACGME Diagnostic Radiology Milestones 2.0: the Time is Now
- Open Access
- 16 March 2022
- Published by Springer Nature in Journal of Intensive Care
- Vol. 10 (1) , 1-16
Brain death: a clinical overview
Brain death, also commonly referred to as death by neurologic criteria, has been considered a legal definition of death for decades. Its determination involves many considerations and subtleties. In this review, we discuss the philosophy and history of brain death, its clinical determination, and special considerations. We discuss performance of the main clinical components of the brain death exam: assessment of coma, cranial nerves, motor testing, and apnea testing. We also discuss common ancillary tests, including advantages and pitfalls. Special discussion is given to extracorporeal membrane oxygenation, target temperature management, and determination of brain death in pediatric populations. Lastly, we discuss existing controversies and future directions in the field.
- 16 March 2022
- Published by Springer Nature in Journal of Intensive Care
- Vol. 10 (1) , 1-16
Open AccessBrain death: a clinical overview
Brain death, also commonly referred to as death by neurologic criteria, has been considered a legal definition of death for decades. Its determination involves many considerations and subtleties. In this review, we discuss the philosophy and history of brain death, its clinical determination, and special considerations. We discuss performance of the main clinical components of the brain death exam: assessment of coma, cranial nerves, motor testing, and apnea testing. We also discuss common ancillary tests, including advantages and pitfalls. Special discussion is given to extracorporeal membrane oxygenation, target temperature management, and determination of brain death in pediatric populations. Lastly, we discuss existing controversies and future directions in the field.
- 1 November 2021
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 48 (6) , 409-411
A roadmap towards pollution prevention and sustainable development of Gadolinium
- 1 November 2021
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 48 (6) , 409-411
A roadmap towards pollution prevention and sustainable development of Gadolinium